MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Adaptive Deep Brain Stimulation for Parkinson’s Disease: from tolerability to patient preference and clinical outcomes

    A. Nakajima, G. Oyama, Y. Shimo, H. Kamo, A. Umemura, H. Iwamuro, Y. Sekiguchi, A. Tsuchiya, T. Brionne, K. Noel, N. Hattori (Tokyo, Japan)

    Objective: To characterize patient preference and clinical outcomes in subjects receiving adaptive Deep Brain Stimulation (aDBS) for Parkinson’s Disease (PD). Background: Local field potential (LFP)…
  • 2023 International Congress

    Huntingtonism and bilateral basal ganglia hypointensity in a male with an XK variant but no McLeod red cell phenotype

    J. Yu, R. Walker, A. Danek, C. Westhoff, S. Vege, I. Itin (Cleveland, USA)

    Objective: To report a novel variant of XK without the characteristic RBC phenotype Background: XK disease (previously called McLeod Syndrome) is a rare X-linked disorder…
  • 2023 International Congress

    Novel digital marker detects minor hallucinations online at home of patients with Parkinson’s disease

    L. Albert, F. Bernasconi, J. Potheegadoo, B. Herbelin, O. Blanke (Geneva, Switzerland)

    Objective: The aim is to develop a novel implicit and quantitative marker for minor hallucinations (MH) in Parkinson’s disease (PD) for a better tracking of…
  • 2023 International Congress

    User Experience (UX): Successful Remote Engagement Strategy for Individuals at Risk for Parkinson’s Disease in PPMI

    L. Lemon, R. Dobkin, M. Kuhl, K. Fabrizio, C. Stanley, L. Heathers, C. Hobbick, B. Mcmahon, M. Totten, K. Marek (New Haven, USA)

    Objective: Describe participant engagement practices for progressive User Experience (UX) in a remote risk screening study. Background: Digital instruments continue to gain footing in clinical…
  • 2023 International Congress

    Levodopa-entacapone-carbidopa-infusion treatment in Parkinson’s disease: A six-month follow-up study

    V. Viljaharju, T. Mertsalmi, KAM. Pauls, M. Koivu, J. Eerola-Rautio, M. Udd, E. Pekkonen (Helsinki, Finland)

    Objective: Objectives of this study were to evaluate changes in medication, adverse events and early discontinuations of levodopa-entacapone-carbidopa-intestinal-gel (LECIG) treatment in advanced Parkinson’s disease (PD).…
  • 2023 International Congress

    Multimodal neuroimaging of Parkinson’s disease with diffusion tensor imaging (DTI) and dopamine transporter (DAT) positron emission tomography

    P. Honhar, S. Tinaz, M. Dias, R. Comley, S. Finnema, R. Carson, D. Scheinost, D. Matuskey (New Haven, USA)

    Objective: The main aims of this study were to characterize brain microstructure alterations in a cross-sectional cohort of Parkinson’s disease (PD) with DTI and assess…
  • 2023 International Congress

    Automatic cluster analysis using semantic relatedness for verbal fluency tasks in Parkinson’s disease

    T. Hähnel, T. Feige, J. Kunze, A. Epler, A. Frank, J. Bendig, N. Schnalke, M. Wolz, P. Themann, B. Falkenburger (Dresden, Germany)

    Objective: The aim of this work was to develop and validate a method for automated identification of semantically related clusters for verbal fluency tasks (VFT)…
  • 2023 International Congress

    Using Long read sequencing to identify complex structural variants in PRKN-PD

    K. Daida, M. Funayama, A. Miano-Burkhardt, L. Mailik, K. Billingsley, M. Ishiguro, H. Yoshino, K. Ogaki, G. Oyama, R. Nonaka, W. Akamatsu, C. Blauwendraat, N. Hattori (Bethesda, USA)

    Objective: Identify complex structural variants in PRKN gene from Parkinson’s disease patients. Background: PRKN is the most frequent causative gene in young onset Parkinson's disease…
  • 2023 International Congress

    Impact of Image-Guided Programming (IGP) in Bilateral STN Deep Brain Stimulation on Programming Time and Setting Outcomes

    J. Aldred, T. Zesiewicz, M. Okun, J. Ramirez-Castaneda, L. Verhagen-Mehtman, C. Luca, R. Ramdhani, J. Durphy, Y. Bezchlibnyk, J. Carlson, K. Foote, S. Sani, A. Papanastassiou, J. Jagid, D. Weintraub, J. Pilitsis, B. Reese, L. Chen, R. Jain (Spokane, USA)

    Objective: To determine if an image-guided programming (IGP) tool can enable shorter initial Deep Brain Stimulation (DBS) programming sessions and evaluate continued chronic use of…
  • 2023 International Congress

    Preliminary report of cerebellar transcranial focused ultrasound for primary orthostatic tremor

    J-F. Nankoo, T. Cortez Grippe, J. Ingratta, S. Mustafa, N. Raies, N. Drummond, G. Darmani, A. Lozano, R. Chen (Toronto, Canada)

    Objective: To investigate the effectiveness of MRI-guided cerebellar transcranial ultrasound stimulation (TUS) for the treatment of primary orthostatic tremor (POT). Background: POT is a rare…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley